Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium crystal-associated diseases

P B Halverson1

  • 1Medical College of Wisconsin, St. Joseph's Hospital, Milwaukee 53210, USA.

Current Opinion in Rheumatology
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Calcium crystal-induced inflammation.

Current opinion in rheumatology·2001
Same author

Nonsteroidal antiinflammatory drugs: benefits, risks, and COX-2 selectivity.

Orthopedic nursing·2000
Same author

Intracellular calcium responses to basic calcium phosphate crystals in fibroblasts.

Osteoarthritis and cartilage·1999
Same author

The spondyloarthropathies.

Orthopedic nursing·1997
Same author

Extraarticular manifestations of rheumatoid arthritis.

Orthopedic nursing·1995
Same author

Phosphocitrate prevents disease progression in murine progressive ankylosis.

Arthritis and rheumatism·1993
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Calcium crystals, like calcium pyrophosphate dihydrate, may worsen arthritis. Their extracellular breakdown is enhanced by spermine, spermidine, and alkaline phosphatase, offering potential therapeutic targets for crystal-induced joint damage.

Area of Science:

  • Rheumatology
  • Biochemistry
  • Orthopedics

Background:

  • The role of calcium-containing crystals in arthritis pathogenesis remains unclear.
  • Existing evidence suggests a correlation between crystal presence and arthritis severity.
  • Calcium pyrophosphate dihydrate (CPPD) crystals are implicated in various arthropathies.

Purpose of the Study:

  • To investigate the impact of CPPD crystals on osteoarthritis development in an animal model.
  • To explore mechanisms of CPPD crystal elimination.
  • To examine the genetic and depositional characteristics of different calcium-containing crystals.

Main Methods:

  • Utilized a lapine meniscectomy model of osteoarthritis.
  • Introduced CPPD crystals into the surgical model to assess cartilage damage.

Related Experiment Videos

  • Investigated extracellular enzymatic degradation of CPPD crystals.
  • Analyzed genetic linkage in familial CPPD disease.
  • Examined crystal deposition in tumoral and non-tumoral tissues.

    • Main Results:

    • CPPD crystals exacerbated cartilage damage in the osteoarthritis model compared to meniscectomy alone.
    • Extracellular enzymatic degradation of CPPD crystals was observed, enhanced by spermine, spermidine, and alkaline phosphatase.
    • Familial CPPD disease exhibited genetic heterogeneity, with some families not linking to chromosome 8q.
    • Tumoral CPPD crystal deposition occurred without widespread chondrocalcinosis.
    • Hydroxyapatite crystals were found in ligamenta flava but not tumoral deposits.
    • Magnesium whitlockite crystals were present in both osteoarthritic and normal cartilage.

    Conclusions:

    • CPPD crystals contribute to cartilage damage in osteoarthritis.
    • Enzymatic degradation pathways offer potential therapeutic strategies for crystal-induced arthritis.
    • Genetic and clinical presentations of CPPD crystal deposition disease are diverse.
    • Different calcium-containing crystals (CPPD, hydroxyapatite, magnesium whitlockite) have distinct deposition patterns and potential pathobiology.